Serial 90072083
Live / Registered — Registered (as of 28 Dec 2021)
What this means for you
Registered since 28 Dec 2021. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90072083
- Registration number
- 6600089
- Mark type
- Design / logo
- Filed
- 24 Jul 2020
- Published for opposition
- 12 Oct 2021
- Registered
- 28 Dec 2021
- Attorney of record
- Patrice P. Jean
Goods and services
- Class 005 — Pharmaceuticals: Epigenetic drugs for the treatment, diagnosis, detection and prevention of cancer; epigenetic drugs targeting arginine methylation in cancer; pharmaceutical preparations in the nature of inhibitors of arginine methylation for the treatment of cancer; pharmaceutical preparations in the nature of inhibitors of protein arginine methyl-transferase (PRMT) for the treatment of cancer; cancer treatment vaccines; therapeutic vaccines for treating cancer; cancer therapy subsection vaccines; pharmaceutical compounds for the treatment, diagnosis, detection and prevention of cancer; pharmaceutical products, preparations and substances for the treatment, diagnosis, detection and prevention of cancer; biological preparations and substances for the treatment, diagnosis, detection and prevention of cancer
- Class 042 — Scientific and technological services: Research and development services in the pharmaceutical and biotechnology fields; medical research and development services in the pharmaceutical and biotechnology fields; scientific research and development services; pharmaceutical research and development services; research and development in the field of epigenetic drugs for the treatment, diagnosis, detection and prevention of cancer; research and development in the field of epigenetic drugs targeting arginine methylation in cancer; research and development in the field of inhibitors of arginine methylation for the treatment of cancer; research and development in the field of inhibitors of protein arginine methyl-transferase (PRMT) for the treatment of cancer; research and development in the field of cancer treatment vaccines, therapeutic vaccines for treating cancer and cancer therapy subsection vaccines; research and development in the field of compounds for the treatment, diagnosis, detection and prevention of cancer; research and development in the field of pharmaceutical products, preparations and substances for the treatment, diagnosis, detection and prevention of cancer; research and development in the field of biological preparations and substances for the treatment, diagnosis, detection and prevention of cancer; consultancy, advisory and information services relating to and connected with the aforementioned services
Owner
- Argonaut Therapeutics Limited, Oxford, GB
- Argonaut Therapeutics Limited, Oxford, GB
- Argonaut Therapeutics Limited, Oxford, GB
Prosecution history
- 28 Dec 2021 — REGISTERED-PRINCIPAL REGISTER
- 12 Oct 2021 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 12 Oct 2021 — PUBLISHED FOR OPPOSITION
- 22 Sept 2021 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 03 Sept 2021 — LAW OFFICE PUBLICATION REVIEW COMPLETED
- 03 Sept 2021 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 03 Sept 2021 — EXAMINER'S AMENDMENT ENTERED
- 03 Sept 2021 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 03 Sept 2021 — EXAMINERS AMENDMENT E-MAILED
- 03 Sept 2021 — EXAMINERS AMENDMENT -WRITTEN
- 12 Aug 2021 — ASSIGNED TO EXAMINER
- 07 Jul 2021 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 07 Jul 2021 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 07 Jul 2021 — ASSIGNED TO LIE
- 17 May 2021 — TEAS RESPONSE TO OFFICE ACTION RECEIVED